Cytokinetics | CYTK - Loan Capital


Cytokinetics reported $1.12B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Amgen USD 50B 2.43B Dec/2025
Bayer EUR 31.83B 877M Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cytokinetics USD 1.12B 957.23M Dec/2025
Eisai JPY 134.77B 12M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Geron USD 119.55M 283K Dec/2025
Halozyme Therapeutics USD 2.14B 1.34B Dec/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 29.59B 5.35B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026